ALGN Medical Devices · Dental tech · Clear aligners · Global healthcare · Thesis updated June 14, 2026

Invisalign pricing finally stopped slipping

In Q1 2026, Clear Aligner revenue rose 7.4% to $856 million, about 82% of company revenue.
Case volume grew 6.7%, and average selling price rose 0.8% to $1,250 per case.
Systems and Services revenue was nearly flat, up only 0.9% to $184 million.
Operating margin was 13.6%, which shows some stability after 2025 restructuring costs.
The key question is whether one good pricing quarter can become a real recovery.

01 Running thesis

One quarter changes the argument

Align's core story improved in Q1 2026. Clear Aligner volume rose 6.7% from last year, and average selling price, or the money Align gets per case, rose 0.8% to $1,250. That matters because 2025 looked like a trade: sell more cases, but cut price to do it.

The bull case is now easier to see. If Invisalign case volume keeps rising while price holds, Align can spread its costs over more sales. That could lift margins after the 2025 restructuring. The 13.6% operating margin in Q1 2026 is not great for a company that once earned higher margins, but it does suggest the reset may be stabilizing.

The bear case is not gone. Q1 2026 is one quarter, and the pricing lift could have help from foreign exchange or mix that does not last. Systems and Services grew only 0.9%, so the scanner and dental software side is not giving Align much help right now.

Finn's view is balanced. Align still owns a strong dental brand and a useful digital workflow. But growth and performance need more proof before this looks like a clean turnaround.

May 2026▲Q1 2026 showed the first real challenge to the 2025 bear case. Clear Aligner revenue rose 7.4%, case volume rose 6.7%, and revenue per case rose 0.8% to $1,250.

Feb 2026→The 2025 Form 10-K confirmed the main tension. Clear Aligner volume rose 4.7% for the year, but average selling price fell 3.9% and operating margin compressed to 13.5% after restructuring and other charges.

Nov 2025→Q3 2025 shifted the concern from demand to profit. Clear Aligner revenue grew 2.4% on 4.9% case growth, but ASP fell 2.4% and gross margin was hurt by restructuring and impairment charges.

Aug 2025▼Q2 2025 reinforced the bear case. Clear Aligner revenue fell 3.3% as revenue per case dropped 3.5% to $1,250, mostly from mix and discounts.

May 2025▼Q1 2025 was a sharp negative data point. Clear Aligner ASP fell 8.1%, offsetting 6.2% case volume growth, while Systems and Services slowed to 1.2% growth.

Feb 2025→The 2024 Form 10-K showed a split business. Systems and Services grew 16.0%, but Clear Aligner revenue in the Americas fell 2.5% and ASP pressure remained clear.

Nov 2024→Q3 2024 kept the same debate alive. Systems and Services grew 15.6%, but Clear Aligner revenue fell 1.0% and the Americas were down 4.7%.

Aug 2024→The initial view framed Align as a two-part story. iTero and services were growing fast, while the much larger Invisalign business was nearly flat and facing lower prices.

02 Business model

Selling cases, scanners, and workflow

Align makes most of its money by selling Invisalign treatment packages to orthodontists and general dentists. The dentist buys the case from Align, then treats the patient. Align also sells retainers, training, and other non-case products tied to clear aligner treatment.

The second business sells iTero intraoral scanners, scanner software, disposables, and exocad CAD/CAM software used by dental labs. A scanner replaces a messy physical mold with a digital scan of the mouth. That scan can feed into Invisalign planning and other dental work.

The model works best when the two parts support each other. A dentist who buys an iTero scanner may be more likely to send Invisalign cases to Align. That creates a sticky system, but it also means scanner weakness can slow one of Align's long-term growth paths.

Where it can break is price. Clear aligners face competition from other brands and from in-office 3D printing. If dentists or patients push for cheaper options, Align may have to discount, which hurts revenue per case and margins.

03 Product portfolio

The dental stack

Cash cow

Invisalign system

This is Align's main product line. It includes clear aligner treatment packages such as Comprehensive, Moderate, Lite, Express, and First.

Steady

Vivera retainers

Vivera retainers help patients keep their teeth in place after treatment. They add repeat revenue tied to the Invisalign base.

Growth engine

iTero scanners

iTero scanners take digital 3D scans of the mouth for orthodontic and restorative dental work. The iTero Lumina scanner, launched in 2024, adds photorealistic 3D images.

Steady

Align and iTero software

Tools like Align Oral Health Suite and iTero Design Suite help dentists plan, show, and manage care. Software makes the scanner more useful and can keep dentists inside Align's system.

Option

exocad CAD/CAM software

exocad serves dental labs and supports digital design and manufacturing workflows. It gives Align a wider role in dental work beyond clear aligners.

Option

Cubicure direct 3D printing

Align bought Cubicure in 2024 for proprietary direct 3D printing technology. The long-term idea is to make devices without first creating molds.

04 Business segments

Still an Invisalign company

Clear Aligner82%modest

Systems and Services18%flat

Segment mix is from Q1 2026 revenue. Clear Aligner was about 82% of revenue, so pricing in Invisalign still drives the whole company.

05 Risk factors

What could break the recovery

ASP slide returns

High impact · Medium odds

Average selling price was the biggest problem in 2025. Q1 2026 showed a 0.8% increase, but that is only one quarter. If discounts, cheaper product mix, or country mix push ASP down again, volume growth may not turn into better profit.

We watchClear Aligner revenue per case, especially whether it stays at or above $1,250 in later 2026 quarters.

Scanner cycle stays weak

Medium impact · High odds

Systems and Services grew only 0.9% in Q1 2026. That suggests dentists are still cautious about buying equipment like iTero scanners. If scanner growth stays flat, Align loses an important way to lock dentists into its digital system.

We watchSystems and Services revenue growth and any management comments on iTero demand.

Clear aligner competition

High impact · Medium odds

Invisalign faces other clear aligner makers and new in-office 3D printing tools. These can give dentists cheaper choices. The risk is not only lost cases, but lower prices to defend share.

We watchDiscounting comments, Clear Aligner ASP, and case growth in the Americas.

Consumer spending pressure

Medium impact · Medium odds

Clear aligners are often a large out-of-pocket purchase for families. When consumers feel squeezed, they can delay treatment. That can hurt case volume even if dentists still like the product.

We watchTeen case growth, total case volume, and management comments on patient conversion rates.

Geopolitical and manufacturing shocks

Medium impact · Medium odds

Align has iTero operations headquartered in Israel and manufacturing exposure in Mexico. The company has warned about conflict near Israel and gang activity near Mexico operations. A supply disruption could hurt scanner supply, aligner production, or costs.

We watchAny filing updates on Israel operations, Mexico manufacturing, supply chain delays, or higher freight and production costs.

AI and data regulation

Medium impact · Medium odds

Align uses patient data, software, and machine learning in dental workflows. The company has warned that AI rules are changing, including in the European Union. Bad algorithms, privacy failures, or new rules could add costs or legal risk.

We watchNew AI regulation disclosures, cybersecurity incidents, and any product delays linked to software review.

06 Quick answers

In one breath

How does Align Technology make money?

Align mainly sells Invisalign clear aligner cases to orthodontists and dentists. It also sells iTero scanners, scanner software, disposables, retainers, and dental lab software.

Why does average selling price matter so much for ALGN?

Average selling price shows how much Align earns per clear aligner case. In 2025, volume grew while price fell, which hurt margins. Q1 2026 was important because both volume and price rose.

Is Align Technology a turnaround stock?

It could be, but the proof is still early. Q1 2026 challenged the bear case, yet Systems and Services is weak and operating margin is still low versus stronger periods.

What should investors watch next?

Watch Clear Aligner ASP, case volume, Systems and Services growth, and operating margin. The best signal would be several quarters where price holds and margin moves into the mid-to-high teens.